Stock listing
Frankfurt:S5YA Sigma Healthcare Ltd Aktie
German listing (Frankfurt) of Sigma Healthcare Ltd · home listing ASX:SIG
Follow Sigma Healthcare Ltd into a list and get an email when it puts out news.
Share price · FWB:S5YA
€1.72 EUR -0.01 (-0.6%)
Close on Nov 19, 2026
Past year +5.9% · daily closes, Nov 19, 2025 – Nov 6, 2026, adjusted for splits- Day range
- €1.72 – €1.72 EURNov 19, 2026
- Market cap
- €19.78B EURAt the close on Nov 19, 2026 · price × 11.50B shares outstanding
- 52-week range
- €1.52 – €1.84 EURLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- €54 EURMedian day 0 shares · 47 days with no trades · last 3 months, Aug 19, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|
| ASX:SIG · Home | $2.89 AUD | -0.01 (-0.3%) | 13,055,894 | $2.88 | $2.91 | $2.87 | $2.90 | Close on Nov 20, 2026 |
|---|
| OTC:SIGGF | $1.90 USD | 0.00 (0.0%) | — | $1.90 | $1.90 | $1.90 | $1.90 | Close on Nov 6, 2026 |
|---|
| Frankfurt:S5YA | €1.72 EUR | -0.01 (-0.6%) | — | €1.72 | €1.72 | €1.72 | €1.73 | Close on Nov 19, 2026 |
|---|
Daily closes
Last 3 months, Aug 19, 2026 – Nov 6, 2026 · FWB:S5YA · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|
| €1.692 | 0.00 | 0.0% | €1.693 | €1.693 | €1.692 | 0 |
|---|
| €1.692 | +0.007 | +0.4% | €1.694 | €1.694 | €1.687 | 0 |
|---|
| €1.685 | -0.01 | -0.6% | €1.681 | €1.69 | €1.68 | 0 |
|---|
| €1.695 | +0.017 | +1.0% | €1.695 | €1.695 | €1.695 | 0 |
|---|
| €1.678 | -0.007 | -0.4% | €1.678 | €1.678 | €1.678 | 0 |
|---|
| €1.685 | +0.004 | +0.2% | €1.685 | €1.685 | €1.685 | 404 |
|---|
| €1.681 | +0.006 | +0.4% | €1.682 | €1.689 | €1.677 | 0 |
|---|
| €1.675 | -0.001 | -0.1% | €1.675 | €1.675 | €1.675 | 40 |
|---|
| €1.676 | -0.022 | -1.3% | €1.676 | €1.676 | €1.676 | 0 |
|---|
| €1.698 | +0.03 | +1.8% | €1.69 | €1.706 | €1.69 | 10 |
|---|
| €1.668 | +0.002 | +0.1% | €1.668 | €1.668 | €1.668 | 626 |
|---|
| €1.666 | -0.001 | -0.1% | €1.666 | €1.666 | €1.666 | 0 |
|---|
| €1.667 | -0.046 | -2.7% | €1.667 | €1.667 | €1.667 | 0 |
|---|
| €1.713 | +0.016 | +0.9% | €1.713 | €1.713 | €1.713 | 0 |
|---|
| €1.697 | -0.011 | -0.6% | €1.697 | €1.697 | €1.697 | 0 |
|---|
| €1.708 | +0.016 | +0.9% | €1.708 | €1.708 | €1.708 | 0 |
|---|
| €1.692 | -0.017 | -1.0% | €1.692 | €1.692 | €1.692 | 0 |
|---|
| €1.709 | +0.045 | +2.7% | €1.709 | €1.709 | €1.709 | 0 |
|---|
| €1.664 | +0.011 | +0.7% | €1.664 | €1.664 | €1.664 | 0 |
|---|
| €1.653 | +0.022 | +1.3% | €1.653 | €1.653 | €1.653 | 0 |
|---|
| €1.631 | +0.057 | +3.6% | €1.631 | €1.631 | €1.631 | 0 |
|---|
| €1.574 | -0.027 | -1.7% | €1.574 | €1.574 | €1.574 | 0 |
|---|
| €1.601 | +0.02 | +1.3% | €1.585 | €1.613 | €1.578 | 0 |
|---|
| €1.581 | -0.003 | -0.2% | €1.581 | €1.581 | €1.581 | 0 |
|---|
| €1.584 | +0.019 | +1.2% | €1.584 | €1.584 | €1.584 | 0 |
|---|
| €1.565 | +0.033 | +2.2% | €1.565 | €1.565 | €1.565 | 142 |
|---|
| €1.532 | -0.029 | -1.9% | €1.53 | €1.532 | €1.527 | 0 |
|---|
| €1.561 | +0.032 | +2.1% | €1.561 | €1.561 | €1.561 | 0 |
|---|
| €1.529 | -0.007 | -0.5% | €1.529 | €1.529 | €1.529 | 0 |
|---|
| €1.536 | -0.008 | -0.5% | €1.541 | €1.542 | €1.536 | 0 |
|---|
| €1.544 | -0.022 | -1.4% | €1.544 | €1.544 | €1.544 | 90 |
|---|
| €1.566 | +0.025 | +1.6% | €1.566 | €1.566 | €1.566 | 0 |
|---|
| €1.541 | -0.002 | -0.1% | €1.541 | €1.541 | €1.541 | 0 |
|---|
| €1.543 | +0.008 | +0.5% | €1.543 | €1.543 | €1.543 | 0 |
|---|
| €1.535 | +0.02 | +1.3% | €1.535 | €1.535 | €1.535 | 0 |
|---|
| €1.515 | -0.015 | -1.0% | €1.515 | €1.515 | €1.515 | 230 |
|---|
| €1.53 | -0.037 | -2.4% | €1.53 | €1.53 | €1.53 | 0 |
|---|
| €1.567 | -0.025 | -1.6% | €1.567 | €1.567 | €1.567 | 0 |
|---|
| €1.592 | +0.01 | +0.6% | €1.592 | €1.592 | €1.592 | 0 |
|---|
| €1.582 | -0.005 | -0.3% | €1.582 | €1.582 | €1.582 | 0 |
|---|
| €1.587 | -0.009 | -0.6% | €1.587 | €1.587 | €1.587 | 34 |
|---|
| €1.596 | -0.023 | -1.4% | €1.596 | €1.596 | €1.596 | 0 |
|---|
| €1.619 | -0.006 | -0.4% | €1.619 | €1.619 | €1.619 | 0 |
|---|
| €1.625 | -0.001 | -0.1% | €1.625 | €1.625 | €1.625 | 0 |
|---|
| €1.626 | -0.009 | -0.6% | €1.626 | €1.626 | €1.626 | 0 |
|---|
| €1.635 | +0.007 | +0.4% | €1.635 | €1.635 | €1.635 | 32 |
|---|
| €1.628 | -0.022 | -1.3% | €1.628 | €1.628 | €1.628 | 0 |
|---|
| €1.65 | +0.011 | +0.7% | €1.65 | €1.65 | €1.65 | 0 |
|---|
| €1.639 | +0.003 | +0.2% | €1.639 | €1.639 | €1.639 | 0 |
|---|
| €1.636 | +0.015 | +0.9% | €1.636 | €1.636 | €1.636 | 0 |
|---|
| €1.621 | +0.04 | +2.5% | €1.621 | €1.621 | €1.621 | 246 |
|---|
| €1.581 | -0.123 | -7.2% | €1.581 | €1.581 | €1.581 | 0 |
|---|
| €1.704 | +0.01 | +0.6% | €1.704 | €1.704 | €1.704 | 0 |
|---|
| €1.694 | -0.034 | -2.0% | €1.694 | €1.694 | €1.694 | 0 |
|---|
| €1.728 | +0.015 | +0.9% | €1.728 | €1.728 | €1.728 | 0 |
|---|
| €1.713 | +0.002 | +0.1% | €1.713 | €1.713 | €1.713 | 80 |
|---|
| €1.711 | -0.003 | -0.2% | €1.711 | €1.711 | €1.711 | 0 |
|---|
| €1.714 | -0.022 | -1.3% | €1.714 | €1.714 | €1.714 | 0 |
|---|
- Ticker
- Frankfurt:S5YA
- Asset type
- Stock
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 23, 2026
Latest deck · Oct 21, 2026
Shareholder meeting · 15 slides
Sigma Healthcare Ltd on 6ix
- News releases
- 30 in the last 12 months · 158 in all · newest Nov 10, 2026 · oldest 2016
- Decks
- 47 decks · latest Oct 21, 2026
Where Sigma Healthcare Ltd is listed
Valuation
Statements: Year to Jan 31, 2026 · balance Apr 30, 2026 · price Nov 20, 2026
- Enterprise value
- $35.13B AUD
- P/E
- 46.9×
- EV/sales
- 3.2×
- EV/EBITDA
- 32.4×
- Price/book
- 6.7×
- Gross margin
- 18.1%
- Operating margin
- 9.2%
- Net margin
- 6.6%
- Debt to equity
- 0.4×
- Beta
- No index for this market yet
Forecasts
Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 3.15 AUD · Analysts' mean
- EPS, year to Jun 2027
- 0.075 · 15 analysts
- Revenue, year to Jun 2027
- 12.2B · 16 analysts
Team and board
Officers
| Officer | Role |
|---|
| Mario Verrocchi | CEO – Chemist Warehouse Group, Executive Director |
|---|
| Vikesh Ramsunder | Managing Director and CEO |
|---|
| Danielle Di Pilla | Chief People Officer, Executive Director |
|---|
Board
| Director | Role |
|---|
| Michael Sammells | Chairman, Non-Executive Director |
|---|
| Annette Carey | Non-Executive Director |
|---|
| Chris Roberts | Non-Executive Director |
|---|
| Damien Gance | Non-Executive Director |
|---|
| Danielle Di Pilla | Chief People Officer, Executive Director |
|---|
| Jack Gance | Non-Executive Director |
|---|
| Mario Verrocchi | CEO – Chemist Warehouse Group, Executive Director |
|---|
| Neville Mitchell | Non-Executive Director |
|---|
Events
- Next results
- Feb 24, 2027 (expected)
| Quarter | Results | Share move |
|---|
| Quarter to Jul 31, 2026 | Aug 26, 2026 | −8.4% |
|---|
| Quarter to Jan 31, 2026 | Feb 25, 2026 | −2.0% |
|---|
| Q4 2025 | Mar 20, 2025 | −1.4% |
|---|
| Q4 2023 | Mar 23, 2023 · After close | 0.0% |
|---|
| Q2 2023 | Sep 26, 2022 · Before open | −5.7% |
|---|
| Q4 2022 | Mar 28, 2022 · After close | +1.9% |
|---|
| Q4 2021 | Mar 21, 2021 | +2.3% |
|---|
Open Events
Decks
| Deck | Kind | Slides | Date |
|---|
| Shareholder Meeting (October 2026) | Shareholder meeting | 15 slides | Oct 21, 2026 |
|---|
| FY2026 Earnings Presentation | Earnings | 26 slides | Aug 27, 2026 |
|---|
| H1 2026 Earnings Presentation | Earnings | 21 slides | Feb 26, 2026 |
|---|
| Shareholder Meeting (October 2025) | Shareholder meeting | 13 slides | Oct 22, 2025 |
|---|
| FY2025 Earnings Presentation | Earnings | 27 slides | Aug 27, 2025 |
|---|
| Macquarie Sydney Conference 2025 | Conference | 15 slides | May 6, 2025 |
|---|
| H1 2025 Earnings Presentation | Earnings | 24 slides | Feb 27, 2025 |
|---|
| Shareholder Meeting (January 2025) | Shareholder meeting | 39 slides | Jan 29, 2025 |
|---|
| H1 2025 Earnings Presentation | Earnings | 28 slides | Sep 25, 2024 |
|---|
| Shareholder Meeting (May 2024) | Shareholder meeting | 18 slides | May 30, 2024 |
|---|
All 47 decks
| Deck | Kind | Slides | Date |
|---|
| FY2024 Earnings Presentation | Earnings | 28 slides | Mar 21, 2024 |
|---|
| Investor Presentation (December 2023) | Investor deck | 80 slides | Dec 11, 2023 |
|---|
| H1 2024 Earnings Presentation | Earnings | 24 slides | Sep 20, 2023 |
|---|
| Shareholder Meeting (May 2023) | Shareholder meeting | 16 slides | May 17, 2023 |
|---|
| FY2023 Earnings Presentation | Earnings | 21 slides | Mar 23, 2023 |
|---|
| H1 2023 Earnings Presentation | Earnings | 26 slides | Sep 26, 2022 |
|---|
| Shareholder Meeting (May 2022) | Shareholder meeting | 17 slides | May 12, 2022 |
|---|
| FY2022 Earnings Presentation | Earnings | 20 slides | Mar 29, 2022 |
|---|
| H1 FY2022 Earnings Presentation | Earnings | 20 slides | Sep 21, 2021 |
|---|
| Investor Presentation (July 2021) | Investor deck | 4 slides | July 2021 |
|---|
| Shareholder Meeting (May 2021) | Shareholder meeting | 21 slides | May 12, 2021 |
|---|
| FY2021 Earnings Presentation | Earnings | 24 slides | Mar 23, 2021 |
|---|
| Citi Group Annual Investor Conference 2020 | Conference | 15 slides | Oct 14, 2020 |
|---|
| H1 FY2021 Earnings Presentation | Earnings | 32 slides | Sep 10, 2020 |
|---|
| Shareholder Meeting (May 2020) | Shareholder meeting | 25 slides | May 13, 2020 |
|---|
| FY2020 Earnings Presentation | Earnings | 28 slides | Mar 25, 2020 |
|---|
| Investor Day (November 2019) | Investor day | 62 slides | Nov 26, 2019 |
|---|
| H1 2020 Earnings Presentation | Earnings | 24 slides | Sep 5, 2019 |
|---|
| Shareholder Meeting (May 2019) | Shareholder meeting | 21 slides | May 15, 2019 |
|---|
| FY2019 Earnings Presentation | Earnings | 30 slides | Mar 21, 2019 |
|---|
| Merger or Acquisition (December 2018) | Merger or acquisition | 7 slides | Dec 14, 2018 |
|---|
| H1 2019 Earnings Presentation | Earnings | 26 slides | Sep 6, 2018 |
|---|
| Shareholder Meeting (May 2018) | Shareholder meeting | 21 slides | May 16, 2018 |
|---|
| FY2018 Earnings Presentation | Earnings | 28 slides | Mar 22, 2018 |
|---|
| H1 FY2018 Earnings Presentation | Earnings | 30 slides | Sep 7, 2017 |
|---|
| Sigma Pharmaceuticals — Non-Deal Roadshow (April 2017) | Roadshow | 32 slides | April 2017 |
|---|
| Sigma Pharmaceuticals — FY2017 Earnings Presentation | Earnings | 28 slides | Mar 23, 2017 |
|---|
| Non-Deal Roadshow (October 2016) | Roadshow | 18 slides | Oct 11, 2016 |
|---|
| Sigma Pharmaceuticals — H1 2017 Earnings Presentation | Earnings | 25 slides | September 2016 |
|---|
| Investor Presentation (March 2016) | Investor deck | 19 slides | Mar 30, 2016 |
|---|
| Sigma Pharmaceuticals — FY2016 Earnings Presentation | Earnings | 26 slides | Mar 23, 2016 |
|---|
| Sigma Pharmaceuticals — H1 2016 Earnings Presentation | Earnings | 25 slides | Sep 10, 2015 |
|---|
| FY2015 Earnings Presentation | Earnings | 27 slides | Mar 19, 2015 |
|---|
| H1 2015 Earnings Presentation | Earnings | 26 slides | Sep 11, 2014 |
|---|
| Sigma Pharmaceuticals — FY2014 Earnings Presentation | Earnings | 28 slides | Mar 27, 2014 |
|---|
| Sigma Pharmaceuticals — H1 2014 Earnings Presentation | Earnings | 21 slides | Sep 12, 2013 |
|---|
| Sigma Pharmaceuticals — FY2012 Earnings Presentation | Earnings | 25 slides | Mar 22, 2012 |
|---|
Open Decks
Financials
Annual, in AUD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|
| Revenue | 10.8B | 4.89B | 3.32B | 3.66B | 3.45B | 3.40B | 3.24B | 3.98B | 4.09B | 4.37B |
|---|
| Cost of revenue | 8.88B | 4.56B | 3.13B | 3.44B | 3.25B | 3.19B | 3.06B | 3.70B | 3.81B | 4.08B |
|---|
| Gross profit | 1.96B | 334.1M | 189.8M | 224.1M | 199.4M | 210.6M | 187.8M | 273.2M | 284.4M | 289.5M |
|---|
| Selling, general and administrative | 461.8M | 384.0M | 88.6M | 82.6M | 93.0M | 94.4M | 68.0M | 63.6M | 65.6M | 59.5M |
|---|
| Operating income | 998.0M | 722.6M | -71.9M | -68.9M | -110.2M | -98.4M | -101.0M | -36.4M | 83.4M | 15.2M |
|---|
| Depreciation and amortization | 85.0M | 56.0M | 28.3M | 30.3M | 27.7M | 31.0M | 27.3M | 13.5M | 9.09M | 8.29M |
|---|
| EBITDA | 1.08B | 778.6M | -43.6M | -38.6M | -82.5M | -67.4M | -73.7M | -22.9M | 92.4M | 23.5M |
|---|
| Interest expense | 114.2M | 18.5M | 16.3M | 14.4M | 10.8M | 11.8M | 13.4M | 11.8M | 6.47M | 6.02M |
|---|
| Income before tax | 1.01B | 743.5M | 8.62M | 5.46M | -8.31M | 28.6M | -15.8M | 52.0M | 78.7M | 76.7M |
|---|
| Income tax | 296.4M | 218.0M | 3.31M | 2.44M | -1.97M | -16.5M | -4.29M | 14.9M | 23.3M | 23.2M |
|---|
| Net income | 709.2M | 529.9M | 4.51M | 1.81M | -7.24M | 43.5M | -12.3M | 36.5M | 55.1M | 53.2M |
|---|
| Earnings per share, basic | 0.06 | 0.03 | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | 0.00 | 0.01 | 0.00 |
|---|
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|
| Cash and equivalents | 131.1M | 14.6M | 356.5M | 16.6M | 31.1M | 16.1M | 104.2M | 72.6M | 82.2M | 24.4M |
|---|
| Short-term investments | | | -7.67M | 0 | 14.0K | 0 | | | | |
|---|
| Receivables | 2.01B | 952.7M | 320.0M | 332.5M | 343.3M | 327.3M | 277.7M | 549.4M | 550.5M | 537.0M |
|---|
| Inventory | 1.25B | 383.4M | 221.1M | 324.9M | 321.6M | 349.1M | 315.5M | 343.3M | 350.5M | 322.0M |
|---|
| Current assets | 3.43B | 1.38B | 912.5M | 685.8M | 761.6M | 702.2M | 735.9M | 1.00B | 1.03B | 918.7M |
|---|
| Property, plant and equipment | | 256.1M | 271.8M | 290.9M | 281.6M | 288.3M | 299.4M | 224.1M | 128.5M | 77.9M |
|---|
| Goodwill | 3.63B | 89.1M | 89.1M | 95.2M | 103.0M | 103.0M | 103.0M | 93.1M | 93.1M | 80.8M |
|---|
| Total assets | 8.91B | 1.83B | 1.40B | 1.20B | 1.28B | 1.22B | 1.23B | 1.38B | 1.30B | 1.12B |
|---|
| Accounts payable | 1.30B | 726.4M | 303.4M | 406.0M | 352.3M | 365.5M | 360.0M | 492.8M | 526.5M | 475.3M |
|---|
| Current liabilities | 2.05B | 865.0M | 371.3M | 477.4M | 457.6M | 523.7M | 576.0M | 663.3M | 781.0M | 574.6M |
|---|
| Long-term debt | 752.2M | 855.3M | 0 | 80.0M | 165.0M | 0 | 115.2M | 200.8M | 788.0K | 1.02M |
|---|
| Total debt | 2.02B | 132.1M | 136.6M | 227.0M | 323.4M | 215.2M | 300.2M | 315.8M | 195.8M | 33.2M |
|---|
| Total liabilities | 3.92B | 991.3M | 531.5M | 723.8M | 786.7M | 705.0M | 752.7M | 869.6M | 789.5M | 580.3M |
|---|
| Shareholders' equity | 5.00B | 837.9M | 870.8M | 475.9M | 487.2M | 513.7M | 476.0M | 513.3M | 513.1M | 536.8M |
|---|
| Shares outstanding | 11.5B | 15.7B | 10.6B | 10.3B | 10.2B | 10.3B | 10.1B | 10.1B | 10.3B | 10.7B |
|---|
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|
| Cash from operations | 574.6M | 598.8M | 42.0M | 33.4M | 27.7M | 12.5M | 200.6M | 8.47M | 71.2M | 145.8M |
|---|
| Capital spending | -56.7M | -7.91M | -4.72M | -29.4M | -14.2M | -77.0M | -57.1M | -108.2M | -62.3M | -25.2M |
|---|
| Free cash flow | 517.9M | -323.5M | 37.2M | 3.96M | 13.5M | -64.6M | 143.5M | -99.7M | 8.89M | 120.6M |
|---|
| Cash from investing | 62.6M | -1.60M | 5.73M | -28.6M | -16.6M | 98.8M | -68.4M | -101.6M | -94.5M | -30.5M |
|---|
| Cash from financing | -645.2M | -24.7M | 295.8M | -116.9M | 128.9M | -265.7M | -100.6M | 83.5M | 113.3M | -67.5M |
|---|
| Dividends paid | -378.8M | -17.1M | -9.98M | -15.9M | -19.9M | -1.59M | -30.7M | -41.0M | -55.2M | -55.7M |
|---|
| Share buybacks | | 2.68M | -9.50M | 879.0K | 195.0K | -50.0K | -50.0K | -4.14M | -30.7M | -24.6M |
|---|
| Change in cash | -7.65M | -341.9M | 343.5M | -2.80M | 66.0M | -154.5M | 31.6M | -9.64M | 90.0M | 47.9M |
|---|
Open Financials
Filings
| Filing | Date | Type | Filed with |
|---|
| Change in substantial holding | Nov 10, 2026 | Ownership change notice | ASX |
|---|
| Change of Director's Interest Notice | Nov 1, 2026 | Ownership change notice | ASX |
|---|
| Notification of cessation of securities - SIG | Oct 23, 2026 | Financing | ASX |
|---|
| Sigma AGM Results of Meeting | Oct 21, 2026 | Meeting outcome | ASX |
|---|
| AGM Trading Update - 21 October 2026 | Oct 20, 2026 | Results | ASX |
|---|
| AGM Trading Update - 21 October 2026 | Oct 20, 2026 | Operations update | ASX |
|---|
| AGM Presentation to Shareholders | Oct 20, 2026 | Other filings | ASX |
|---|
| AGM Presentation to Shareholders | Oct 20, 2026 | Other filings | ASX |
|---|
| AGM Chairman & CEO Address to Shareholders | Oct 20, 2026 | Meeting outcome | ASX |
|---|
| AGM Chairman & CEO Address to Shareholders | Oct 20, 2026 | Meeting outcome | ASX |
|---|
All 157 filings
| Filing | Date | Type | Filed with |
|---|
| Sustainability Report 2026 | Oct 9, 2026 | ESG report | ASX |
|---|
| Notice of ceasing to be a substantial holder | Sep 28, 2026 | Ownership change notice | ASX |
|---|
| Change of Director's Interest Notice | Sep 20, 2026 | Ownership change notice | ASX |
|---|
| Notice of Annual General Meeting/Proxy Form | Sep 18, 2026 | Meeting notice | ASX |
|---|
| Change of Director's Interest Notice | Sep 16, 2026 | Ownership change notice | ASX |
|---|
| Appendix 3Y | Sep 6, 2026 | Other filings | ASX |
|---|
| Sigma Corporate Governance Statement 2026 | Aug 26, 2026 | Other filings | ASX |
|---|
| Sigma Full Year Results Presentation | Aug 26, 2026 | Results | ASX |
|---|
| Sigma Full Year Results ASX Release | Aug 26, 2026 | Results | ASX |
|---|
| 2026 Appendix 4E and Annual Report | Aug 26, 2026 | Annual report | ASX |
|---|
| Dividend/Distribution - SIG | Aug 26, 2026 | Dividend | ASX |
|---|
| Appendix 4G | Aug 26, 2026 | Other filings | ASX |
|---|
| Sigma 2026 AGM | Aug 24, 2026 | Meeting notice | ASX |
|---|
| Sigma FY26 Full Year Results Information | Aug 13, 2026 | Results | ASX |
|---|
| Withdrawal from Boots sale process | Jun 14, 2026 | Acquisition or disposal | ASX |
|---|
| Macquarie Australia Conference 2026 - Update | May 4, 2026 | Operations update | ASX |
|---|
| Sigma Half Year Results ASX Release | Feb 25, 2026 | Results | ASX |
|---|
| Half Year Accounts | Feb 25, 2026 | Interim report | ASX |
|---|
| Sigma Half Year Results Presentation | Feb 25, 2026 | Interim report | ASX |
|---|
| AGM Chairman & CEO Address to Shareholders | Oct 21, 2025 | Meeting outcome | ASX |
|---|
| AGM Presentation to Shareholders | Oct 21, 2025 | Other filings | ASX |
|---|
| Appendix 4E & Full Year Financial Report | Aug 26, 2025 | Results | ASX |
|---|
| Sigma Full Year FY25 ASX Release | Aug 26, 2025 | Results | ASX |
|---|
| Sigma Full Year FY25 Results Presentation | Aug 26, 2025 | Other filings | ASX |
|---|
| Trading Update | May 5, 2025 | Other filings | ASX |
|---|
| Sigma Full Year 2024/25 ASX Release | Mar 19, 2025 | Results | ASX |
|---|
| Sigma Appendix 4E & Full Year Financial Report | Mar 19, 2025 | Results | ASX |
|---|
| S&P DJI Announces March 2025 Quarterly Rebalance | Mar 7, 2025 | Other filings | ASX |
|---|
| Sigma FY25 Trading Update | Feb 6, 2025 | Other filings | ASX |
|---|
| Merger with Chemist Warehouse - Scheme Meeting Results | Jan 29, 2025 | Acquisition or disposal | ASX |
|---|
| Merger with Chemist Warehouse - General Meeting Results | Jan 29, 2025 | Meeting outcome | ASX |
|---|
| Trading Halt | Jan 28, 2025 | Trading halt or suspension | ASX |
|---|
| CW - Trading Update 1H FY25 Record Sales & Margin Expansion | Jan 28, 2025 | Operations update | ASX |
|---|
| Sigma - Draft Prospectus | Dec 18, 2024 | Offer document | ASX |
|---|
| Sigma Notice of Meeting | Dec 18, 2024 | Meeting notice | ASX |
|---|
| Chemist Warehouse Scheme Meeting and Scheme Booklet | Dec 13, 2024 | Offer document | ASX |
|---|
| Sigma welcomes the ACCC's decision | Nov 6, 2024 | Other filings | ASX |
|---|
| Half Year Results Presentation | Sep 24, 2024 | Interim report | ASX |
|---|
| Half Yearly Reports & Accounts | Sep 24, 2024 | Interim report | ASX |
|---|
| Half Year Results | Sep 24, 2024 | Results | ASX |
|---|
| Sigma Acknowledges ACCC Announcement | Jun 13, 2024 | Acquisition or disposal | ASX |
|---|
| Boral Limited to be removed from the S&P/ASX 200 Index | May 2, 2024 | Other filings | ASX |
|---|
| Sigma Full Year 2023/24 Results Presentation | Mar 20, 2024 | Other filings | ASX |
|---|
| Sigma Full Year 2023/24 ASX Release | Mar 20, 2024 | Results | ASX |
|---|
| Successful Completion of Retail Entitlement Offer | Jan 23, 2024 | Financing | ASX |
|---|
| Retail Offer Booklet and Letters to Retail Shareholders | Dec 17, 2023 | Offer document | ASX |
|---|
| Reinstatement to Official Quotation | Dec 12, 2023 | Trading halt or suspension | ASX |
|---|
| Institutional Completion Announcement | Dec 12, 2023 | Financing | ASX |
|---|
| Investor Presentation Merger & Equity Raising | Dec 10, 2023 | Acquisition or disposal | ASX |
|---|
| Transformational Merger & Equity Raising | Dec 10, 2023 | Acquisition or disposal | ASX |
|---|
| Voluntary Suspension | Dec 7, 2023 | Trading halt or suspension | ASX |
|---|
| Pause in Trading | Dec 6, 2023 | Trading halt or suspension | ASX |
|---|
| Dividend/Distribution - SIG | Sep 20, 2023 | Dividend | ASX |
|---|
| Half Yearly Report and Accounts | Sep 20, 2023 | Interim report | ASX |
|---|
| Sigma Awarded Chemist Warehouse Supply Contract | Jun 5, 2023 | Other filings | ASX |
|---|
| Sigma Full Year 2022/23 Results Presentation | Mar 22, 2023 | Other filings | ASX |
|---|
| Sigma Full Year 2022/23 ASX Release | Mar 22, 2023 | Other filings | ASX |
|---|
| Business Update - Supplementary Announcement | Mar 10, 2023 | Operations update | ASX |
|---|
| Business Update | Mar 9, 2023 | Operations update | ASX |
|---|
| Sigma secures refinancing of Debt facility | Nov 28, 2022 | Other filings | ASX |
|---|
| Chairman & CEOs Address to Shareholders | May 12, 2022 | Other filings | ASX |
|---|
| Sigma Full Year 2021/22 Results Presentation | Mar 28, 2022 | Other filings | ASX |
|---|
| Sigma Full Year 2021/2022 ASX Release | Mar 28, 2022 | Other filings | ASX |
|---|
| Profit Guidance | Mar 1, 2022 | Guidance | ASX |
|---|
| SIG: Withdrawal of API merger proposal | Nov 4, 2021 | Acquisition or disposal | ASX |
|---|
| SIG: Proposal to merge with API | Sep 26, 2021 | Other filings | ASX |
|---|
| Unsolicited, Non-binding, Conditional Proposal from SIG | Sep 26, 2021 | Other filings | ASX |
|---|
| CEO Appointment | Sep 23, 2021 | Other filings | ASX |
|---|
| ASX Release Half Year Results | Sep 20, 2021 | Interim report | ASX |
|---|
| CEO resignation announcement | Apr 25, 2021 | Other filings | ASX |
|---|
| Sigma Full Year 2020/2021 Results Presentation | Mar 22, 2021 | Other filings | ASX |
|---|
| Sigma Full Year 2020/2021 ASX Release | Mar 22, 2021 | Other filings | ASX |
|---|
| Appendix 4E and Full Year Financial Report | Mar 22, 2021 | Results | ASX |
|---|
| Trading update | Feb 7, 2021 | Other filings | ASX |
|---|
| Half Year 2020/21 Results Presentation | Sep 9, 2020 | Other filings | ASX |
|---|
| Half Year 2020/21 ASX Release | Sep 9, 2020 | Other filings | ASX |
|---|
| Appendix 4D- Half Year Financial Report | Sep 9, 2020 | Interim report | ASX |
|---|
| Sigma sells two Distribution Centres for $172m | Aug 9, 2020 | Other filings | ASX |
|---|
| Industry funding agreement | Jun 16, 2020 | Other filings | ASX |
|---|
| Incoming Chairmans Address | May 13, 2020 | Other filings | ASX |
|---|
| CEOs Address to Shareholders | May 13, 2020 | Other filings | ASX |
|---|
| Chairmans Address to Shareholders | May 13, 2020 | Other filings | ASX |
|---|
| Sigma 2019/2020 Full Year Results Presentation | Mar 24, 2020 | Results | ASX |
|---|
| Sigma 2019/2020 Full Year ASX Release | Mar 24, 2020 | Other filings | ASX |
|---|
| Market Update - Securing our longer-term future | Mar 17, 2020 | Other filings | ASX |
|---|
| Market update | Feb 6, 2020 | Other filings | ASX |
|---|
| Market Update | Dec 12, 2019 | Other filings | ASX |
|---|
| Sigma Investor Day Presentation | Nov 25, 2019 | Other filings | ASX |
|---|
| Market Update - new MC/CW supply agreement | Nov 24, 2019 | Other filings | ASX |
|---|
| Citi Group Investor Conference | Oct 15, 2019 | Other filings | ASX |
|---|
| S&P DJI Announces September 2019 Quarterly Rebalance | Sep 5, 2019 | Other filings | ASX |
|---|
| Sigma 2019/20 Half Year Results Presentation | Sep 4, 2019 | Interim report | ASX |
|---|
| Sigma 2019/20 Half Year ASX Release | Sep 4, 2019 | Other filings | ASX |
|---|
| Appendix 4D - Half year financial report | Sep 4, 2019 | Interim report | ASX |
|---|
| Sigma 2018/2019 Full Year Results Presentation | Mar 20, 2019 | Results | ASX |
|---|
| Sigma 2018/2019 Full Year ASX Release | Mar 20, 2019 | Other filings | ASX |
|---|
| Update on API proposal | Mar 12, 2019 | Other filings | ASX |
|---|
| Debt Refinancing Agreement | Dec 16, 2018 | Other filings | ASX |
|---|
| Rescheduled Investor Briefing | Dec 14, 2018 | Other filings | ASX |
|---|
| API: API announces merger proposal with Sigma | Dec 13, 2018 | Acquisition or disposal | ASX |
|---|
| Company Update | Dec 13, 2018 | Other filings | ASX |
|---|
| Sigma 2018/19 Half Year Results Presentation | Sep 5, 2018 | Interim report | ASX |
|---|
| Sigma 2018/19 Half Year ASX Release | Sep 5, 2018 | Other filings | ASX |
|---|
| CEO Address to Shareholders | May 16, 2018 | Other filings | ASX |
|---|
| Changes relating to buy-back - Appendix 3D | Nov 6, 2017 | Treasury share status | ASX |
|---|
| Settlement reached with My Chemist / Chemist Warehouse | Oct 16, 2017 | Other filings | ASX |
|---|
| 2018 Half Year Media / ASX Release | Sep 6, 2017 | Other filings | ASX |
|---|
| Sigma acquires MPS | Sep 6, 2017 | Acquisition or disposal | ASX |
|---|
| Trading Update - My Chemist/ Chemist Warehouse Group | Jul 25, 2017 | Other filings | ASX |
|---|
| Trading Update - CSO Deed compensation agreed | Jun 28, 2017 | Other filings | ASX |
|---|
| Trading Update - CHS signs Department of Defence agreement | Jun 16, 2017 | Other filings | ASX |
|---|
| Trading Update - My Chemist/Chemist Warehouse Group | May 29, 2017 | Other filings | ASX |
|---|
| Sigma 2016/17 Full Year ASX Release | Mar 22, 2017 | Other filings | ASX |
|---|
| Announcement - Sigma partnership with Fred IT Group | Nov 23, 2016 | Other filings | ASX |
|---|
| Sigma Pharmaceuticals Asian Roadshow 11 - 13 Oct 2016 | Oct 10, 2016 | Other filings | ASX |
|---|
| 2017 Half Year Media/ASX Release | Sep 7, 2016 | Other filings | ASX |
|---|
| Market update - final adjustment for historical class action | May 13, 2016 | Other filings | ASX |
|---|
| Sigma 2015/16 Half Year Report | Mar 30, 2016 | Interim report | ASX |
|---|
| Appointment of Managing Director and CEO | Mar 30, 2016 | Management or board change | ASX |
|---|
| Notification of Approach | Mar 30, 2016 | Other filings | ASX |
|---|
| Board Resignations | Mar 30, 2016 | Other filings | ASX |
|---|
| Resignation of Managing Director and CEO | Mar 30, 2016 | Management or board change | ASX |
|---|
| Chairman`s Address to Shareholders | Mar 30, 2016 | Other filings | ASX |
|---|
| SIP: Update on Proposal from Aspen | Mar 30, 2016 | Other filings | ASX |
|---|
| Sigma Pharmaceuticals Limited - AGM | Mar 30, 2016 | Other filings | ASX |
|---|
| Sigma 2012 Half Year Report | Mar 30, 2016 | Interim report | ASX |
|---|
| Investor Update Presentation | Mar 30, 2016 | Other filings | ASX |
|---|
| Dividend Details | Mar 30, 2016 | Dividend | ASX |
|---|
| SIP: Court Approval of Settlement of Class Action | Mar 30, 2016 | Legal or regulatory action | ASX |
|---|
| Sigma 2013/14 Full Year Report | Mar 30, 2016 | Other filings | ASX |
|---|
| SIP: Market Update | Mar 30, 2016 | Other filings | ASX |
|---|
| Preliminary Final Report | Mar 22, 2016 | Results | ASX |
|---|
| Acquisitions exceed expectations | Feb 11, 2016 | Acquisition or disposal | ASX |
|---|
| Sigma 2014/15 Full Year Report | Feb 10, 2016 | Other filings | ASX |
|---|
| Sigma 2014/15 Half Year Report | Feb 10, 2016 | Interim report | ASX |
|---|
| Sigma 2013/14 Half Year Report | Feb 10, 2016 | Interim report | ASX |
|---|
| Market Update - Announces MOU with Pharmacy Alliance | Feb 10, 2016 | Other filings | ASX |
|---|
| Sigma Settles Class Action | Feb 10, 2016 | Other filings | ASX |
|---|
| Announcement of buy-back - Appendix 3C | Feb 10, 2016 | Treasury share status | ASX |
|---|
| Sigma 2011 Half Year Report | Feb 10, 2016 | Interim report | ASX |
|---|
| Sigma Appointed as Preferred Wholesaler | Feb 10, 2016 | Other filings | ASX |
|---|
| Sigma 2010 Half Year Report | Feb 10, 2016 | Interim report | ASX |
|---|
| Sigma Proposed Sale of Pharmaceuticals Division | Feb 10, 2016 | Other filings | ASX |
|---|
| Response to media speculation | Feb 10, 2016 | Other filings | ASX |
|---|
| Financial Update | Feb 10, 2016 | Other filings | ASX |
|---|
| Update on Proposal from Aspen Group | Feb 10, 2016 | Other filings | ASX |
|---|
| Sigma grants Aspen Pharmacare access to due diligence | Feb 10, 2016 | Other filings | ASX |
|---|
Open Filings
Cap table
Built by 6ix from Sigma Healthcare Ltd’s releases
- Common shares
- 11,502,746,000
- Fully diluted
- 11,502,746,000
Fully diluted
| Line | Shares |
|---|
| Common shares | 11,502,746,000 |
|---|
Share count over time
| Count | Shares |
|---|
| Nov 22, 2026 | 11,502,746,000 |
|---|
Open Cap table
Shareholders
Funds
| Holder | Shares | Value | Change | As of |
|---|
| Vanguard Total International Stock Index Fund | 75.1M | US$155M | +480K | Jul 31, 2026 |
|---|
| Vanguard Developed Markets Index Fund | 49.8M | US$94.9M | +479K | Jun 30, 2026 |
|---|
| iShares Core MSCI EAFE ETF | 39.1M | US$80.5M | +2.36M | Jul 31, 2026 |
|---|
| Fidelity International Index Fund | 19.5M | US$41.3M | +587K | May 31, 2026 |
|---|
| iShares MSCI EAFE ETF | 18M | US$37.2M | −14,448 | Jul 31, 2026 |
|---|
| JPMorgan BetaBuilders Developed Asia Pacific ex-Japan ETF | 17.9M | US$36.9M | +1.8M | Jul 31, 2026 |
|---|
| Vanguard Ftse All-World Ex-Us Index Fund | 12.1M | US$25M | +331K | Jul 31, 2026 |
|---|
| Schwab International Equity ETF | 11.2M | US$23.7M | +2.16M | May 31, 2026 |
|---|
| Fidelity Series Global ex U.S. Index Fund | 10.3M | US$21.3M | +433K | Jul 31, 2026 |
|---|
| Nuveen International Equity Index Fund | 8.59M | US$17.7M | +535K | Jul 31, 2026 |
|---|
Show 50 holders
| Holder | Shares | Value | Change | As of |
|---|
| iShares MSCI EAFE Growth ETF | 7.98M | US$16.5M | +208K | Jul 31, 2026 |
|---|
| iShares Core MSCI Total International Stock ETF | 7.22M | US$14.9M | No change | Jul 31, 2026 |
|---|
| International Core Equity 2 Portfolio | 7.07M | US$14.6M | −114K | Jul 31, 2026 |
|---|
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | 6.52M | US$12.4M | −6,592 | Jun 30, 2026 |
|---|
| iShares ESG Aware MSCI EAFE ETF | 6.03M | US$12.7M | +370K | May 31, 2026 |
|---|
| iShares Core MSCI International Developed Markets ETF | 5.8M | US$12M | +565K | Jul 31, 2026 |
|---|
| Vanguard Pacific Stock Index Fund | 5.5M | US$11.3M | −138K | Jul 31, 2026 |
|---|
| iShares MSCI Australia ETF | 5.27M | US$11.1M | +270K | May 31, 2026 |
|---|
| iShares MSCI Pacific ex Japan ETF | 4.81M | US$10.1M | +40,982 | May 31, 2026 |
|---|
| iShares MSCI EAFE Min Vol Factor ETF | 4.51M | US$9.31M | −82,620 | Jul 31, 2026 |
|---|
| Vanguard Total World Stock Index Fund | 4.15M | US$8.56M | +106K | Jul 31, 2026 |
|---|
| College Retirement Equities Fund - Total Global Stock Account | 3.74M | US$7.13M | +8,155 | Jun 30, 2026 |
|---|
| Schwab International Index Fund | 3.51M | US$7.23M | +138K | Jul 31, 2026 |
|---|
| iShares MSCI EAFE International Index Fund | 3.29M | US$6.27M | +49,802 | Jun 30, 2026 |
|---|
| Fidelity Total International Index Fund | 3.02M | US$6.22M | +204K | Jul 31, 2026 |
|---|
| iShares Global Healthcare ETF | 2.88M | US$5.49M | +159K | Jun 30, 2026 |
|---|
| Fidelity Global ex U.S. Index Fund | 2.72M | US$5.61M | +73,977 | Jul 31, 2026 |
|---|
| Fidelity SAI International Index Fund | 2.17M | US$4.48M | +71,091 | Jul 31, 2026 |
|---|
| Xtrackers MSCI EAFE Hedged Equity ETF | 1.94M | US$4.09M | −30,406 | May 29, 2026 |
|---|
| JPMorgan BetaBuilders International Equity ETF | 1.81M | US$3.73M | +138K | Jul 31, 2026 |
|---|
| Fidelity ZERO International Index Fund | 1.76M | US$3.63M | +157K | Jul 31, 2026 |
|---|
| iShares MSCI ACWI ETF | 1.75M | US$3.62M | −3,932 | Jul 31, 2026 |
|---|
| Dimensional International Core Equity Market ETF | 1.72M | US$3.55M | +221K | Jul 31, 2026 |
|---|
| iShares MSCI ACWI ex U.S. ETF | 1.65M | US$3.4M | +51,788 | Jul 31, 2026 |
|---|
| International Equity Index Fund | 1.57M | US$2.99M | +55,105 | Jun 30, 2026 |
|---|
| Dimensional International Core Equity 2 ETF | 1.52M | US$3.15M | No change | Jul 31, 2026 |
|---|
| iShares Core MSCI Pacific ETF | 1.48M | US$3.05M | +87,622 | Jul 31, 2026 |
|---|
| State Street Global All Cap Equity ex-U.S. Index Portfolio | 1.46M | US$2.79M | No change | Jun 30, 2026 |
|---|
| Fidelity SAI International Momentum Index Fund | 1.43M | US$2.94M | +51,532 | Jul 31, 2026 |
|---|
| International Sustainability Core 1 Portfolio | 1.39M | US$2.87M | −439K | Jul 31, 2026 |
|---|
| Dimensional World ex. U.S. Core Equity 2 ETF | 1.25M | US$2.57M | No change | Jul 31, 2026 |
|---|
| Nuveen ESG International Developed Markets Equity ETF | 1.13M | US$2.32M | +9,644 | Jul 31, 2026 |
|---|
| State Street International Developed Equity Index Portfolio | 1.08M | US$2.05M | +123K | Jun 30, 2026 |
|---|
| Vanguard ESG International Stock ETF | 1.01M | US$2.14M | +169K | May 31, 2026 |
|---|
| Six Circles Managed Equity Portfolio International Unconstrained Fund | 976K | US$1.86M | No change | Jun 30, 2026 |
|---|
| International Vector Equity Portfolio | 890K | US$1.84M | −20,395 | Jul 31, 2026 |
|---|
| Empower International Index Fund | 833K | US$1.59M | No change | Jun 30, 2026 |
|---|
| JNL International Index Fund | 825K | US$1.57M | No change | Jun 30, 2026 |
|---|
| College Retirement Equities Fund - Responsible Balanced Account | 812K | US$1.55M | +87,270 | Jun 30, 2026 |
|---|
| WisdomTree Global ex-U.S. Quality Growth Fund | 807K | US$1.54M | +10,167 | Jun 30, 2026 |
|---|
This page holds 50 of 175 holders. Open Shareholders
Insider trades
| Insider | Trade | Shares | Price | Value | Date |
|---|
| Annette CAREY Director | Buy | 20,000 | AUD 2.75 | AUD 55,000 | Oct 28, 2026 |
|---|
Open Shareholders
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|
| Annette Carey | Non-Executive Director · Since at least Nov 5, 2026 |
|---|
| Chris Roberts | Non-Executive Director · Since at least Nov 5, 2026 |
|---|
| Damien Gance | Non-Executive Director · Since at least Nov 5, 2026 |
|---|
| Danielle Di Pilla | Chief People Officer, Executive Director · Since at least Nov 5, 2026 |
|---|
| Jack Gance | Non-Executive Director · Since at least Nov 5, 2026 |
|---|
| Mario Verrocchi | CEO – Chemist Warehouse Group, Executive Director · Since at least Nov 5, 2026 |
|---|
| Michael Sammells | Chairman, Non-Executive Director · Since at least Oct 20, 2026 |
|---|
| Neville Mitchell | Non-Executive Director · Since at least Nov 5, 2026 |
|---|
| Vikesh Ramsunder | Managing Director and CEO · Since at least Nov 5, 2026 |
|---|
Open People
Log in to ask 6ix AI your own questions about Sigma Healthcare Ltd.